Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price

External Link - Source: The Washington Post

Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus treatment.

This entry was posted in Pharmaceuticals and tagged . Bookmark the permalink.